‘MYINTS 3 MINUTE VEGGIES’ PROMISE WHOLESOME VEGETARIAN READY-TO-EAT MEALS
The days of lockdown without cooks, cleaners or any outside help, are still fresh in memory. This difficult period undoubtedly gave birth to home chefs...
Continue ReadingGUBBA PHARMA IN E NEWS
The Increasing Use Of AI In The Pharmaceutical Industry
The pharmaceutical industry has long relied on cutting edge technologies to help deliver safe, reliable drugs to market. With the recent pandemic, it’s proved more...
Continue Reading
Piramal Enterprises looking at acquisition of multiple pharma assets, possible re-entry into domestic formulations
Acquisitions of niche manufacturing capabilities for a Contract Development and Manufacturing Organisation, hospital generics business to sell specialised products in over 100 countries, and organic...
Continue Reading
Dr Reddy’s says ‘slight’ delay in commercial rollout of Sputnik V vaccine
Dr Reddy’s has said there is a “slight postponement” in the timeline of the commercial launch of Sputnik V coronavirus vaccine due to dependency on...
Continue Reading
Exclusive webinar organised by Gubba in collaboration with Darda associates on ‘ Production linked incentive scheme’
PLI for API/KSM/DI [PLI 1.0] was launched last year in March 2020 for the incentive outlay of INR 6,940 crores for which 47 approvals have...
Continue Reading
IRM India Affiliate To Strengthen Risk-Readiness In The Indian Pharmaceutical Sector
Globally, the pharma industry has undergone a rapid change over the last year, with the demand generated from the COVID pandemic overshadowing other treatment areas...
Continue Reading
Bayer, Zydus extend pharma JV by 3 years
German chemical and pharma major Bayer and Ahmedabad-based Cadila Healthcare on Monday extended their pharmaceuticals joint venture by three years from June 2021. The companies...
Continue Reading
Overcoming the Challenges of API Complexity
Pharmaceutical drug molecules are becoming increasingly complex, posing challenges in formulation development and manufacturing. This is particularly true of small molecule drug APIs and peptides,...
Continue Reading
Zydus Cadila, gets permission for clinical trials of antibodies cocktail to treat Covid-19
The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of Covid-19 has been given permission...
Continue Reading